preloader

Pathology low back pain sciatica herniated disc – Myoton Diagnosis – CBD

  • Home
  • -
  • Research
  • -
  • Pathology low back pain sciatica herniated disc – Myoton Diagnosis – CBD
Pathology low back pain sciatica herniated disc – Myoton Diagnosis – CBD

Interest of Myoton Pro in the evaluation of lumbosciatica of disc origin on the biomechanical parameters of tone, elasticity and rigidity.

Lumbo-sciatica of disc origin is an important public health problem with significant socio-professional impacts. Cannabis contains several cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), which are undergoing extensive research into their physiological and therapeutic effects. Unlike THC, the interest of CBD lies in the fact that it lacks psychotropic effects and is well tolerated. Patients with lumbosciatica disc could benefit from treatment with CBD, as it has shown promising results in the management of spasticity, pain and anxiety, which could make it an interesting alternative or complement to current treatments, which sometimes They are often unsatisfactory due to their low effectiveness.

However, to date, few studies have been conducted, possibly due to the stigma associated with medicinal cannabis. Before carrying out a clinical study on the benefit of CBD in the context of lumbo-sciatica disc, we consider it essential to present an innovative measurement tool, the Myoton Pro. This is due to its ease and speed of use, its reproducibility and both intra- and inter-operator reliability, and its ability to provide biomechanical data (tone, stiffness, elasticity) that will contribute to the understanding of the physiological mechanisms of CBD in lumbo-sciatica disc.

Subscribe to our
Newsletter

***We promise not to spam.

×